These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16037098)

  • 1. Identification of CD36 molecular features required for its in vitro angiostatic activity.
    Primo L; Ferrandi C; Roca C; Marchiò S; di Blasio L; Alessio M; Bussolino F
    FASEB J; 2005 Oct; 19(12):1713-5. PubMed ID: 16037098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shear stress modulates the expression of thrombospondin-1 and CD36 in endothelial cells in vitro and during shear stress-induced angiogenesis in vivo.
    Bongrazio M; Da Silva-Azevedo L; Bergmann EC; Baum O; Hinz B; Pries AR; Zakrzewicz A
    Int J Immunopathol Pharmacol; 2006; 19(1):35-48. PubMed ID: 16569344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diallyl trisulfide inhibits angiogenic features of human umbilical vein endothelial cells by causing Akt inactivation and down-regulation of VEGF and VEGF-R2.
    Xiao D; Li M; Herman-Antosiewicz A; Antosiewicz J; Xiao H; Lew KL; Zeng Y; Marynowski SW; Singh SV
    Nutr Cancer; 2006; 55(1):94-107. PubMed ID: 16965246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity.
    Kawamura H; Li X; Harper SJ; Bates DO; Claesson-Welsh L
    Cancer Res; 2008 Jun; 68(12):4683-92. PubMed ID: 18559514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of infiltration and angiogenesis by thrombospondin-1 in papillary thyroid carcinoma.
    Tanaka K; Sonoo H; Kurebayashi J; Nomura T; Ohkubo S; Yamamoto Y; Yamamoto S
    Clin Cancer Res; 2002 May; 8(5):1125-31. PubMed ID: 12006528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
    Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
    Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antiangiogenic effect of thrombospondin-2 is mediated by CD36 and modulated by histidine-rich glycoprotein.
    Simantov R; Febbraio M; Silverstein RL
    Matrix Biol; 2005 Feb; 24(1):27-34. PubMed ID: 15748999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondin-1 modulates VEGF signaling via CD36 by recruiting SHP-1 to VEGFR2 complex in microvascular endothelial cells.
    Chu LY; Ramakrishnan DP; Silverstein RL
    Blood; 2013 Sep; 122(10):1822-32. PubMed ID: 23896411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Priming of the vascular endothelial growth factor signaling pathway by thrombospondin-1, CD36, and spleen tyrosine kinase.
    Kazerounian S; Duquette M; Reyes MA; Lawler JT; Song K; Perruzzi C; Primo L; Khosravi-Far R; Bussolino F; Rabinovitz I; Lawler J
    Blood; 2011 Apr; 117(17):4658-66. PubMed ID: 21378271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
    Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
    Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH
    Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mediators of angiogenesis in bladder cancer.
    Campbell SC; Volpert OV; Ivanovich M; Bouck NP
    Cancer Res; 1998 Mar; 58(6):1298-304. PubMed ID: 9515819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syndecan-4 contributes to endothelial tubulogenesis through interactions with two motifs inside the pro-angiogenic N-terminal domain of thrombospondin-1.
    Nunes SS; Outeiro-Bernstein MA; Juliano L; Vardiero F; Nader HB; Woods A; Legrand C; Morandi V
    J Cell Physiol; 2008 Mar; 214(3):828-37. PubMed ID: 17879962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
    Jung MH; Lee SH; Ahn EM; Lee YM
    Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro.
    Weigand M; Hantel P; Kreienberg R; Waltenberger J
    Angiogenesis; 2005; 8(3):197-204. PubMed ID: 16328160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF.
    Dardik R; Inbal A
    Exp Cell Res; 2006 Oct; 312(16):2973-82. PubMed ID: 16914140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capillary sprout endothelial cells exhibit a CD36 low phenotype: regulation by shear stress and vascular endothelial growth factor-induced mechanism for attenuating anti-proliferative thrombospondin-1 signaling.
    Anderson CR; Hastings NE; Blackman BR; Price RJ
    Am J Pathol; 2008 Oct; 173(4):1220-8. PubMed ID: 18772338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin-triggered Lipoxin A4 inhibition of VEGF-induced endothelial cell migration involves actin polymerization and focal adhesion assembly.
    Cezar-de-Mello PF; Nascimento-Silva V; Villela CG; Fierro IM
    Oncogene; 2006 Jan; 25(1):122-9. PubMed ID: 16132039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Jun N-terminal kinase activation is required for the inhibition of neovascularization by thrombospondin-1.
    Jiménez B; Volpert OV; Reiher F; Chang L; Muñoz A; Karin M; Bouck N
    Oncogene; 2001 Jun; 20(26):3443-8. PubMed ID: 11423995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.